Search Prime Grants

U54CA221705

Cooperative Agreement

Overview

Grant Description
1/2 TUFCCC/HC regional comprehensive cancer health disparity partnership
Awardee
Temple University-Of The Commonwealth System Of Higher Education
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.397 - Cancer Centers Support Grants
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Philadelphia, Pennsylvania 191405104 United States
Geographic Scope
Single Zip Code
Related Opportunity
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) (PAR-22-249)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/23 to 08/31/28 and the total obligations have increased 698% from $1,671,024 to $13,330,548.
Temple University-Of The Commonwealth System Of Higher Education was awarded 1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership Cooperative Agreement U54CA221705 worth $13,330,548 from National Cancer Institute in September 2018 with work to be completed primarily in Philadelphia Pennsylvania United States. The grant has a duration of 10 years and was awarded through assistance program 93.397 Cancer Centers Support Grants. The Cooperative Agreement was awarded through grant opportunity Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 9/24/25

Period of Performance
9/19/18
Start Date
8/31/28
End Date
73.0% Complete

Funding Split
$13.3M
Federal Obligation
$0.0
Non-Federal Obligation
$13.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA221705

Subgrant Awards

Disclosed subgrants for U54CA221705

Transaction History

Modifications to U54CA221705

Additional Detail

Award ID FAIN
U54CA221705
SAI Number
U54CA221705-761346452
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
QD4MGHFDJKU1
Awardee CAGE
1QBP4
Performance District
PA-03
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $11,572,880 98%
Modified: 9/24/25